MedPath

Investigating the effect of colchicine on left ventricular function based on conventional and strain echocardiography

Phase 3
Recruiting
Conditions
Acute anterior STEMI.
ST elevation (STEMI) myocardial infarction of anterior wall
I21.0
Registration Number
IRCT20231223060504N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
96
Inclusion Criteria

All patients with acute anterior STEMI will be included in the study.

Exclusion Criteria

stroke in the last 3 months
Type 2 Index MI
CABG in the last 3 years or decision to undergo surgery
History of non-skin malignancies in the last 3 years
Inflammatory bowel disease (IBD)
Chronic diarrhea
Neuromuscular diseases with a CK level greater than 3 times the maximum normal (except for diseases that have led to muscle infarction)
Chronic hematological diseases
Current treatment with corticosteroids or other anti-inflammatory drugs
Known sensitivity to colchicine or current chronic treatment with Colchicine
Severe kidney failure (Cr>2 upper limit of the normal range)
Severe liver failure
History of alcohol or drug abuse

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eft ventricle function. Timepoint: The effect of colchicine on left ventricular function at the beginning of the study (before the start of the intervention) and 4 to 6 weeks after administration. Method of measurement: Echocardiography machine.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath